Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/XUP stock hub

FRA/XUP has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/XUPis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

424.3M

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/XUPFRA/XUP

—

Loading chart…

In the news

Latest news · FRA/XUP

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-368.3

P25 n/aP50 n/aP75 n/a

ROIC-198.2

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/XUP market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

169

Groups with data

Currency

EUR

Showing 169 of 169 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	France
Country code	DE
Employees	188
Employees Change	8%
Employees Change Percent	4.44
Enterprise value	EUR 473.9M
Exchange	Frankfurt Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 424.3M
Price	EUR 8.32
Price currency	EUR
Rev Per Employee	348,047.87x
Sic	2836
Symbol	fra/XUP
Website	https://www.genfit.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-20.26%
EV Earnings	-5.51x
EV/FCF	-17.15x
EV/Sales	7.24x
FCF yield	-6.51%
P/B ratio	-18.83x
P/S ratio	6.48x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-81.96%
EBITDA Margin	-79.15%
Gross margin	100%
Gross Profit	EUR 65.4M
Gross Profit Growth	45%
Gross Profit Growth Q	211.76%
Gross Profit Growth3 Y	-6.66%
Gross Profit Growth5 Y	17.5%
Net Income	EUR -86M
Pretax Margin	-132.19%
Profit Margin	-131.38%
Profit Per Employee	EUR -457,277
ROA	-21.59
Roa5y	-5.78
ROCE	-61.84
ROE	-368.3
Roe5y	-58.56
ROIC	-198.2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-11.12%
Cagr15y	5.46%
Cagr1y	109.05%
Cagr3y	31.42%
Cagr5y	18.03%
FCF Growth Q	-86.68%
OCF Growth Q	-85.56%
Revenue Growth	-7.44x
Revenue Growth Q	211.76x
Revenue Growth3 Y	-6.66x
Revenue Growth5 Y	17.5x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.42
Assets	EUR 159M
Cash	EUR 101.1M
Current Assets	EUR 144.3M
Current Liabilities	EUR 72.3M
Debt	EUR 150.7M
Debt FCF	EUR -5.45
Equity	EUR -22.5M
Interest Coverage	-44.69
Liabilities	EUR 181.6M
Long Term Assets	EUR 14.8M
Long Term Liabilities	EUR 109.3M
Net Cash	EUR -49.6M
Net Cash By Market Cap	EUR -11.69
Tangible Book Value	EUR -26.7M
Tangible Book Value Per Share	EUR -0.53

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2
Net Working Capital	EUR 13.8M
Quick ratio	1.96
Working Capital	EUR 72M
Working Capital Turnover	EUR 1.46

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.07%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-69.23%
1Y total return	108.94%
200-day SMA	5.38
3Y total return	127.01%
50-day SMA	8.54
50-day SMA vs 200-day SMA	50over200
5Y total return	129.08%
All Time High	69.47
All Time High Change	-88.02%
All Time High Date	2015-02-20
All Time Low	1.18
All Time Low Change	606.88%
All Time Low Date	2011-11-23
ATR	0.27
Ch YTD	58.63
High	8.32
High52	9.34
High52 Date	2026-04-16
High52ch	-10.92%
Low	8.32
Low52	3.01
Low52 Date	2025-09-26
Low52ch	176.78%
Ma50ch	-2.56%
Price vs 200-day SMA	54.56%
RSI	49.69
RSI Monthly	68.96
RSI Weekly	64.96
Sharpe ratio	1.57x
Sortino ratio	2.9
Total Return	-0.07%
Tr YTD	58.63
Tr15y	121.97%
Tr1m	11.23%
Tr1w	4%
Tr3m	33.01%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -53.6M
Operating margin	-81.96

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	40,836,947%
Net Borrowing	51,379,000
Shares Insiders	0.29%
Shares Institutions	0.26%
Shares Qo Q	0.79%
Shares Yo Y	0.07%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -27.9M
Average Volume	20.5x
Bv Per Share	-0.45
CAPEX	EUR -1.4M
Ch10y	-70.15
Ch15y	113.3
Ch1m	11.23
Ch1w	4
Ch1y	108.9
Ch3m	33.01
Ch3y	127
Ch5y	129.1
Ch6m	139.1
Change	-3.82%
Change From Open	0
Close	8.65
Days Gap	-3.82
Depreciation Amortization	1,843,000
Earnings Date	2026-09-29
EBIT	EUR -53.6M
EBITDA	EUR -51.8M
EPS	EUR -1.72
F Score	3
FCF	EUR -27.6M
FCF EV Yield	-5.83x
Financing CF	48,985,000
Fiscal Year End	December
Founded	1,999
Income Tax	EUR -531,000
Investing CF	-3,631,000
Is Primary Listing	0
Last Earnings Date	2026-04-02
Last Report Date	2025-12-31
Ma150	6.04
Ma150ch	37.77%
Ma20	8.48
Ma20ch	-1.91%
Net CF	19,305,000
Next Earnings Date	2026-09-29
Open	8.32
Ppne	7,100,000
Price Date	2026-05-08
Relative Volume	20x
Revenue	65,433,000x
SBC By Revenue	0.47x
Share Based Comp	308,000
Tax By Revenue	-0.81x
Tr6m	139.08%
Z Score	-3.74

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/XUP pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/XUP stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/XUP?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.3%

Share of float held by funds and institutions

Insider ownership

+0.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

FRA/XUP momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

49.7

Neutral momentum band

Price vs 200-day MA

+54.6%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.57

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/XUP

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/XUP stock rating?

fra/XUP is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/XUP analysis?

The full report lives at /stocks/fra/XUP/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/XUP?

The latest report frames fra/XUP around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/XUP page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.